PitchBook Alternative
Why do former PitchBook customers love DealForma?
DealForma is a biopharma database specializing in licensing deals in addition to verified venture and M&A as an alternative to PitchBook.
Comprehensive Coverage
DealForma provides the most extensive coverage of biopharmaceutical transactions, including licensing deals, asset purchases, mergers, acquisitions, research partnerships, and funding rounds, ensuring you have access to a vast repository of relevant data.
In-Depth Analytics
With granular and relevant filters, DealForma allows you to delve into transaction details, track trends, and gain valuable insights into deal structures, valuations, therapeutic areas, and key players, enabling strategic planning, market analysis, and competitive intelligence.
Advanced Deal Monitoring
Business developers are switching to DealForma for its advanced deal monitoring capabilities. The platform enables you to set up alerts for specific criteria, such as target companies, indications, or modalities so you stay informed about the latest developments and deal opportunities.
Finally, a deals database built specifically for biopharma.
DealForma stands out as the best in biopharma deal data with its comprehensive coverage of biotech and pharma licensing and funding transactions by providing a superior experience when it comes to deal terms. We focus on delivering high-quality deal data so you can have confidence that you are getting complete and accurate information for your biopharma business development deal comps and benchmark research.
PitchBook
Built for Biopharma
PitchBook
Intuitive / Fast Interface
PitchBook
Data Quality / 100% Analyst Checked
PitchBook
Licensing Deals
PitchBook
M&A Deals
PitchBook
Contracts and License Agreements
PitchBook
Private Funding Rounds
PitchBook
Biopharma License Deal Comps, Upfronts, Options, Milestones, R&D Funding, Royalties, Profit Splits, etc.
PitchBook
Deal Structures and Asset Stages
PitchBook
Deals going back to 2008, Updated Daily
PitchBook
Company financials and Investor Profiles
PitchBook
Discovery to Clinical Drug Pipelines
PitchBook
Biopharma-Specific Filters for Stage, Indication, Modality, Target, etc.
PitchBook
Data Visualization / Analytics Dashboards
Full Tableau
PitchBook
Source Documents for Every Deal and Funding Record (e.g., Press Releases, SEC-Filed Contracts, Regulatory Docs)
PitchBook
Drug Sales Figures, Quarterly and Regional Breakouts, with Company Filing Sources
PitchBook
Unlimited Data Export to Excel
Unlimited
PitchBook
Saved Searches and Alerts
PitchBook
VC Analysis
PitchBook
Company-Provided Valuations
PitchBook
Analyst Hours Included
20
PitchBook
3
Minimum Starting Price
$18,000
PitchBook
$40,000
Comparison based on customer feedback and public information gathered January 2024 to the best of our knowledge. We understand the world is constantly changing, so if you see we missed a feature or made a mistake, let us know.
DealForma vs. PitchBook
PitchBook is widely recognized for its expertise in venture capital analysis and company-provided valuations across various industries. DealForma is focused on biopharma, so deal comps, therapeutic areas, modalities, discovery and clinical stages, and targets are intentionally curated to give you the most relevant data on biotech and pharma business development, licensing, and funding. DealForma is built for biopharma, from the data to the attached sources and contracts.
Why are biopharma and finance companies switching to DealForma?
DealForma is a Better Deal Database
We keep hearing from business developers who have tried other databases and DealForma. They are switching to DealForma because of the deal-focused filters and the ability to quickly pull relevant deal comps knowing the content is high-quality. This saves them time when creating reports because the information is verified and up-to-date.
Intuitive, Modern Interface
You know that biopharma business development is full of complex terminology. But you shouldn’t have to remember how a database codes things. DealForma designed its platform from the ground up to make finding the most relevant information fast and easy. DealForma’s granular filters give you the confidence in working with the right data.
Intentional Biopharma Deal Curation
Analysts at DealForma have experience reading thousands of deal and funding announcements and company filings. Teams assigned to each segment look for key terms to separate out from a noisy news flow. And they do this manually, every day, so you can quickly filter through decades of carefully curated, relevant transaction profiles.
Inclusive Analyst Support
DealForma goes beyond a mere database by providing you 20 hours of analyst time per year included with your subscription for you to leverage the expertise of skilled professionals to assist you in data interpretation, perform custom analyses, and provide valuable insights tailored to specific business needs.
DealForma is the most trusted data partner for biopharma deal benchmarks.
Discover why people love DealForma
Top 10 Pharma Company
Bellwether Analytics (previously)
Flagship Pioneering (previously)
Life Sciences Advisory
Want to see how DealForma
can speed up your business development research?
Schedule your personalized 30-minute demo today.
We’ll hop on a screen-sharing call to show you exactly how DealForma can help you find the info you’ve been spending tons of time digging up.
